"
Team:Imperial College London/M2
From 2009.igem.org
(Difference between revisions)
| Line 37: | Line 37: | ||
<tr><td width="0%"></td> | <tr><td width="0%"></td> | ||
| - | <td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/ | + | <td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/EncapsulationRationale"><b>Acid Protection</b></a></center></td> |
<td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/Modelling"><b>Modelling</b></a></center></td> | <td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/Modelling"><b>Modelling</b></a></center></td> | ||
Revision as of 09:41, 7 October 2009
Module 2 - Encapsulsation Overview
Aside from aiding in pill manufacture, encapsulation (Module 2) allows the safe passage of polypetides through the stomach into the intestine. The encapsulation process involves the production of a physical barrier, acid resistance proteins and the preservative trehalose. Without encapsulation, our polypeptides would be denatured and degraded by stomach acid and digestive proteases respectively.
About proteolysis.
Our solution represents a fusion between probiotic treatment & polypeptide encapsulation
